Other Cancers Cytogenetic Abnormalities Impact Outcomes in Ixazomib vs Placebo for MM: Pooled Analysis Jun 01, 2023
Colorectal Cancer,Gastrointestinal Cancer Evaluating the Efficacy of GDC-6036 in Advanced Solid Tumors with KRAS G12C Mutation Jun 01, 2023
Other Cancers Pelabresib and Ruxolitinib Combination vs Placebo and Ruxolitinib in JAK Inhibitor-Naïve MF Jun 01, 2023
Melanoma,Skin Cancer 1L Atezolizumab With Vemurafenib and Cobimetinib Improves OS in BRAFV600 Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer NNT and NNH Utilized to Assess the Efficacy and Safety of Adjuvant Therapies in Melanoma Jun 01, 2023
Melanoma,Skin Cancer Tumor Biomarker Analysis of Encorafenib + Binimetinib in Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer Before or After: The Debate on Pembrolizumab Administration for High-Risk Melanoma Jun 01, 2023
Colorectal Cancer,Gastrointestinal Cancer Botensilimab Plus Balstilimab in Heavily Pretreated MSS CRC: Phase 1A/1B Results Jun 01, 2023
